BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27832260)

  • 21. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
    Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
    Barentsen R; van de Weijer PH; Schram JH
    Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
    Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
    Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
    Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
    JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia.
    Constantine G; Millheiser LS; Kaunitz AM; Parish SJ; Graham S; Bernick B; Mirkin S
    Menopause; 2019 Nov; 26(11):1259-1264. PubMed ID: 31688572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.
    Archer DF; Labrie F; Montesino M; Martel C
    J Steroid Biochem Mol Biol; 2017 Nov; 174():1-8. PubMed ID: 28323042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data.
    Constantine GD; Simon JA; Pickar JH; Archer DF; Bernick B; Graham S; Mirkin S
    Curr Med Res Opin; 2018 Dec; 34(12):2131-2136. PubMed ID: 30238814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women.
    Mitchell CM; Guthrie KA; Larson J; Diem S; LaCroix AZ; Caan B; Shifren JL; Woods NF; Heiman JR; Lindau ST; Reed SD
    Menopause; 2019 Aug; 26(8):816-822. PubMed ID: 30994576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
    Simon JA; Maamari RV
    Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.
    Simon JA; Kagan R; Archer DF; Constantine GD; Bernick B; Graham S; Mirkin S
    Climacteric; 2019 Aug; 22(4):412-418. PubMed ID: 30862193
    [No Abstract]   [Full Text] [Related]  

  • 33. The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.
    Constantine GD; Simon JA; Pickar JH; Archer DF; Kushner H; Bernick B; Gasper G; Graham S; Mirkin S;
    Menopause; 2017 Apr; 24(4):409-416. PubMed ID: 27922936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monurelle Biogel
    Nappi RE; Cagnacci A; Becorpi AM; Nappi C; Paoletti AM; Busacca M; Martella S; Bellafronte M; Tredici Z; Di Carlo C; Corda V; Vignali M; Bagolan M; Sardina M
    Climacteric; 2017 Oct; 20(5):467-475. PubMed ID: 28657769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
    Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P
    Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.
    Vale F; Rezende C; Raciclan A; Bretas T; Geber S
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women.
    Karimi FZ; Nazari N; Rakhshandeh H; Mazloum SR
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():41-45. PubMed ID: 37044017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation.
    Mitchell CM; Ma N; Mitchell AJ; Wu MC; Valint DJ; Proll S; Reed SD; Guthrie KA; Lacroix AZ; Larson JC; Pepin R; Raftery D; Fredricks DN; Srinivasan S
    Am J Obstet Gynecol; 2021 Aug; 225(2):159.e1-159.e15. PubMed ID: 33675793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.